2024-512152-38-00招募中2 期
Tumour heterogeneity studies based on dedicated breast PET using proliferation radiotracers: early detection of the treatment response - MIBIOTIMI
Fundacion Instituto De Investigacion Sanitaria De Santiago De Compostela1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2024年11月15日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 入组人数
- 100
- 试验地点
- 1
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 65+ years（65+ Years, 18-64 Years）
- 性别
- Female
- 接受健康志愿者
- 是
入选标准
- 未提供
排除标准
- 未提供
研究者
Virginia Pubul Núñez
Scientific
Fundacion Instituto De Investigacion Sanitaria De Santiago De Compostela
研究点 (1)
Loading locations...
相似试验
招募中
不适用
Characterisation of tumour heterogeneity and identification of adaptive resistance mechanisms of metastatic castration-resistant prostate carcinomaC61Malignant neoplasm of prostateDRKS00028021Klinik für Nuklearmedizin am Universitätsklinikum Augsburg45
Unknown
不适用
Comparing tumour heterogeneity in primary tumour, circulating tumour cells and metastasesSCLC niet kleincellig longcarcinoom, longkankerlungcancer, tumour heterogeneity, tumor heterogeniteit, CTC, circulating tumour cell, circulerende tumor celNL-OMON29203niversity Medical Centre Groningen30
尚未招募
不适用
Comparing tumour heterogeneity in primary tumour, circulating tumour cells and its metastaseslungcancer1002765510029107NL-OMON45251niversitair Medisch Centrum Groningen50
已完成
不适用
An integrated multi-omics study of tumor heterogeneity in patients with treatment-resistant malignant cancermalignant cancerJPRN-UMIN000040181Kansai Electric Power Hospital100
尚未招募
Unknown
Fluorodeoxyglucose (FDG) and human epidermal growth factor receptor 2 (HER2) positron emission tomography (PET) scan in breast cancerCancer - BreastBreast cancerACTRN12624000918527Fiona Stanley Hospital10